Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: Design of a community-based cluster-randomized trial

BMC Pregnancy and Childbirth

Volumn 12, Issue , 2012, Pages

  Stanton, Cynthia K ^a   Newton, Samuel ^b   Mullany, Luke C ^a   Cofie, Patience ^c   Agyemang, Charlotte T ^b   Adiibokah, Edward ^b   Darcy, Niamh ^d   Khan, Sadaf ^e   Levisay, Alice ^e   Gyapong, John ^f   Armbruster, Deborah ^g   Owusu Agyei, Seth ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

^c PATH   (Ghana)

^d RTI INTERNATIONAL   (United States)

^e PATH   (United States)

^f UNIVERSITY OF GHANA   (Ghana)

^g UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

Oxytocin; Postpartum hemorrhage; Randomized trial; Uterotonics

Indexed keywords

OXYTOCIN;

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; FOLLOW UP; GHANA; HOME DELIVERY; HUMAN; LABOR ONSET; MATERNAL CARE; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTPARTUM HEMORRHAGE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL AREA;

BLOOD VOLUME; COMMUNITY HEALTH WORKERS; DRUG STORAGE; FEMALE; GHANA; HOME CHILDBIRTH; HUMANS; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; RESEARCH DESIGN;

EID: 84861847252     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-12-42     Document Type: Article

References (32)

1. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010, 375(9726):1609-1623. 10.1016/S0140-6736(10)60518-1, 20382417.
2. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-1074. 10.1016/S0140-6736(06)68397-9, 16581405.
3. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000, 2:000007.
4. WHO WHO Recommendations for the Prevention of Postpartum Haemorrhage 2007, WHO.
5. FIGO, ICM Joint Statement 2003, The Hague, London, FIGO, ICM.
6. Mathai M, Gulmezoglu AM, Hill S. Saving womens lives: evidence-based recommendations for the prevention of postpartum haemorrhage. Bull World Health Organ 2007, 85(4):322-323. 2636323, 17546315.
7. Walraven G, Blum J, Dampha Y, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 2005, 112(9):1277-1283. 10.1111/j.1471-0528.2005.00711.x, 16101608.
8. Høj L, Placido C, Bruun B, et al. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005, 331(7519):723. 10.1136/bmj.331.7519.723, 1239973, 16195287.
9. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006, 368(9543):1248-1253. 10.1016/S0140-6736(06)69522-6, 17027730.
10. Gulmezoglu AM, Villar F, Hofmeyr GJ. Prostaglandins for postpartum haemorrhage (Cochrane Review). The Cochrane Library 2004, 3.
11. Buekens P, Althabe F. Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin. Lancet 2010, 375(9710):176-178. 10.1016/S0140-6736(10)60066-9, 20109901.
12. PATH A HealthTech Historical Profile 2005, The Uniject Device, Seattle, PATH.
13. Strand RT, et al. Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration. Acta Obstet Gynecol Scand 2005, 84(3):260-265.
14. Jangsten ES, Strand R. Gomez de Freitas E, Hellstrom A, Johansson A, Bergstrom S: Women's perceptions of pain and discomfort after childbirth in Angola. African Journal of Reproductive Health 2005, 9(3):148-158. 10.2307/3583421, 16623199.
15. Althabe FM, Mazzoni A, Cafferata M, Gibbons L, Karolinski A, Armbruster D, Buekens P, Belizan J. Using Uniject ot increase the use of prophylactic oxtyocin for management of the third stage of labor in Latin America. Int J Gynaecol Obstet 2011, 114:184-189. 10.1016/j.ijgo.2011.05.003, 21693378.
16. Tsu VD, Sutanto A, Vaidya K, et al. Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia. Int J Gynaecol Obstet 2003, 83(1):103-11. 10.1016/S0020-7292(03)00186-3, 14511884.
17. POPPHI Pilot use of oxytocin in a Uniject device for AMTSL in Mali 2008, Evaluation of the safety and feasibility of a new delivery technology, Seattle, POPPHI.
18. Tsu VD, Mai T, Nguyen Y, Luu H. Reducing postpartum hemorrhage in Vietnam: Assessing the effectiveness of active management of third-stage labor. J Obstet Gynaecol Res 2006, 32(5):489-496. 10.1111/j.1447-0756.2006.00436.x, 16984516.
19. Tsu VD, Luu H, Mai T. Does a novel prefilled injection device make postpartum oxytocin easier to administer? Results from midwives in Vietnam. Midwifery 2009, 25:461-465. 10.1016/j.midw.2007.10.010, 18281131.
20. WHO 1993, Stability of injectable oxytocics in tropical climates, Geneva, WHO.
21. Kirkwood BR, Hurt L, Amenga-Etego S, et al. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. Lancet 2010, 375(9726):1640-1649. 10.1016/S0140-6736(10)60311-X, 20435345.
22. Ryan P. Random allocation of treatments in blocks (sxd1_4). Stata Journal 2008, 8(4):594.
23. Patel A, Goudar SS, Geller SE, et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 2006, 93(3):220-224. 10.1016/j.ijgo.2006.02.014, 16626718.
24. Hayes RJ, Moulton LH. Cluster Randomized Trials 2009, Chapman & Hall/CRC, Boca Raton.
25. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44(4):1049-1060. 10.2307/2531734, 3233245.
26. WHO Managing Complications in Pregnancy and Childbirth 2000, A guide for midwives and doctors, Geneva, WHO.
27. Konje JC, Odukoya OA, Ladipo OA. Ruptured uterus in Ibadan-a twelve year review. Int J Gynaecol Obstet 1990, 32(3):207-213. 10.1016/0020-7292(90)90347-N, 1972111.
28. Zheng Q. Analysis of 39 cases of maternal deaths caused by incorrect use of oxytocin. Zhonghua Fu Chan Ke Za Zhi 1994, 29(5):276-277. 316-317.
29. Lan KK, DeMets DL. Discrete sequential boundaries for clinical trials: a generalized estimating equation approach. Biometrika 1983, 70:659-663.
30. O'Brien PF, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979, 35(3):549-556. 10.2307/2530245, 497341.
31. Blum J, Winikoff B, Raghavan S, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010, 375(9710):217-223. 10.1016/S0140-6736(09)61923-1, 20060162.
32. Winikoff B, Dabash R, Durocher J, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010, 375(9710):210-216. 10.1016/S0140-6736(09)61924-3, 20060161.